Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Escobar

Showing results (61-70 of 368) with videos related to

Pageof 37
Sort By:
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 25, 2010
Aliskiren in the management of hypertensionVivencio Barrios, Carlos Escobar
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|June 2, 2012
What is the place of percutaneous coronary intervention in the management of stable angina?Carlos Escobar, Vivencio Barrios
Future Cardiology|May 15, 2013
Can dabigatran improve blood pressure control?Vivencio Barrios, Carlos Escobar
Hypertension (Dallas, Tex. : 1979)|April 30, 2008
Gender differences in left ventricular hypertrophy regressionCarlos Escobar, Vivencio Barrios
International Journal of Cardiology|October 9, 2012
Should angiotensin receptor blockers be the cornerstone of antihypertensive treatment in patients with obesity?Vivencio Barrios, Carlos Escobar
Revista Espanola De Cardiologia (English Ed.)|October 8, 2018
Vaccination in Patients With Heart Disease. How Long Should We Wait?Vivencio Barrios, Carlos Escobar
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 22, 2020
Changing paradigms: from prevention of thromboembolic events to improved survival in patients with atrial fibrillationCarlos Escobar, A John Camm
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 3, 2021
Should we make the risk stratification process more complex in patients with atrial fibrillation? Authors' replyCarlos Escobar, A John Camm
Journal of Clinical Medicine|April 13, 2024
Rosuvastatin-Based Lipid-Lowering Therapy for the Control of LDL Cholesterol in Patients at High Vascular RiskJose María Mostaza, Carlos Escobar
Revista Medica De Chile|August 2, 2024
[Perspective of primary care physicians on the management of dyslipidaemia in patients without atherosclerotic cardiovascular disease: a cross-sectional study]Vicente Pascual Fuster, Carlos Escobar
Pageof 37

Showing results (61-70 of 368) with videos related to

Sort By:
Pageof 37
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 25, 2010
Aliskiren in the management of hypertensionVivencio Barrios, Carlos Escobar
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|June 2, 2012
What is the place of percutaneous coronary intervention in the management of stable angina?Carlos Escobar, Vivencio Barrios
Future Cardiology|May 15, 2013
Can dabigatran improve blood pressure control?Vivencio Barrios, Carlos Escobar
Hypertension (Dallas, Tex. : 1979)|April 30, 2008
Gender differences in left ventricular hypertrophy regressionCarlos Escobar, Vivencio Barrios
International Journal of Cardiology|October 9, 2012
Should angiotensin receptor blockers be the cornerstone of antihypertensive treatment in patients with obesity?Vivencio Barrios, Carlos Escobar
Revista Espanola De Cardiologia (English Ed.)|October 8, 2018
Vaccination in Patients With Heart Disease. How Long Should We Wait?Vivencio Barrios, Carlos Escobar
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 22, 2020
Changing paradigms: from prevention of thromboembolic events to improved survival in patients with atrial fibrillationCarlos Escobar, A John Camm
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 3, 2021
Should we make the risk stratification process more complex in patients with atrial fibrillation? Authors' replyCarlos Escobar, A John Camm
Journal of Clinical Medicine|April 13, 2024
Rosuvastatin-Based Lipid-Lowering Therapy for the Control of LDL Cholesterol in Patients at High Vascular RiskJose María Mostaza, Carlos Escobar
Revista Medica De Chile|August 2, 2024
[Perspective of primary care physicians on the management of dyslipidaemia in patients without atherosclerotic cardiovascular disease: a cross-sectional study]Vicente Pascual Fuster, Carlos Escobar
Pageof 37